Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7519507rdf:typepubmed:Citationlld:pubmed
pubmed-article:7519507lifeskim:mentionsumls-concept:C0016053lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C1333568lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C1416655lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C1706382lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C0376544lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C0879468lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C1150625lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C1690540lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:7519507lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:7519507pubmed:issue3-4lld:pubmed
pubmed-article:7519507pubmed:dateCreated1994-9-2lld:pubmed
pubmed-article:7519507pubmed:abstractTextThree receptor molecules, belonging to the class III of receptor tyrosine kinases, namely the receptors for colony-stimulating factor 1, CSF1R (product of the FMS proto-oncogene) and Steel factor, SLFR (product of the KIT proto-oncogene), as well as the recently identified FLT3/FLK2 gene product, appear to play distinct roles in normal hematopoietic differentiation. Their potential role in leukemic hematopoiesis has been approached by expression studies in hematopoietic malignancies, especially in acute leukemias of the myeloid and lymphoid lineages. We present here a review of available data, and discuss the possible significance and potential applications of these results.lld:pubmed
pubmed-article:7519507pubmed:languageenglld:pubmed
pubmed-article:7519507pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:citationSubsetIMlld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7519507pubmed:statusMEDLINElld:pubmed
pubmed-article:7519507pubmed:monthAprlld:pubmed
pubmed-article:7519507pubmed:issn1042-8194lld:pubmed
pubmed-article:7519507pubmed:authorpubmed-author:BirnbaumDDlld:pubmed
pubmed-article:7519507pubmed:authorpubmed-author:BirgFFlld:pubmed
pubmed-article:7519507pubmed:authorpubmed-author:RosnerMMlld:pubmed
pubmed-article:7519507pubmed:authorpubmed-author:CarbucciaNNlld:pubmed
pubmed-article:7519507pubmed:issnTypePrintlld:pubmed
pubmed-article:7519507pubmed:volume13lld:pubmed
pubmed-article:7519507pubmed:geneSymbolKITlld:pubmed
pubmed-article:7519507pubmed:geneSymbolFLT1lld:pubmed
pubmed-article:7519507pubmed:geneSymbolFLT3lld:pubmed
pubmed-article:7519507pubmed:geneSymbolCSF1Rlld:pubmed
pubmed-article:7519507pubmed:geneSymbolCSF1R/FMSlld:pubmed
pubmed-article:7519507pubmed:geneSymbolFLK2SLFRlld:pubmed
pubmed-article:7519507pubmed:geneSymbolFLT3/FLK2lld:pubmed
pubmed-article:7519507pubmed:geneSymbolSLFR/KITlld:pubmed
pubmed-article:7519507pubmed:ownerNLMlld:pubmed
pubmed-article:7519507pubmed:authorsCompleteYlld:pubmed
pubmed-article:7519507pubmed:pagination223-7lld:pubmed
pubmed-article:7519507pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:meshHeadingpubmed-meshheading:7519507-...lld:pubmed
pubmed-article:7519507pubmed:year1994lld:pubmed
pubmed-article:7519507pubmed:articleTitleThe expression of FMS, KIT and FLT3 in hematopoietic malignancies.lld:pubmed
pubmed-article:7519507pubmed:affiliationLaboratoire d'Hématologie Moléculaire, Unité 119 de l'INSERM, Marseille, France.lld:pubmed
pubmed-article:7519507pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7519507pubmed:publicationTypeReviewlld:pubmed